2-151650316-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3PP5
The NM_001164508.2(NEB):c.7291G>A(p.Glu2431Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000349 in 1,461,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001164508.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.7291G>A | p.Glu2431Lys | missense_variant | Exon 54 of 182 | 5 | NM_001164508.2 | ENSP00000380505.3 | ||
NEB | ENST00000427231.7 | c.7291G>A | p.Glu2431Lys | missense_variant | Exon 54 of 182 | 5 | NM_001164507.2 | ENSP00000416578.2 | ||
NEB | ENST00000409198.5 | c.7291G>A | p.Glu2431Lys | missense_variant | Exon 54 of 150 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000803 AC: 2AN: 248946Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135032
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461612Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727098
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Nemaline myopathy 2 Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2431 of the NEB protein (p.Glu2431Lys). This variant is present in population databases (rs767302772, gnomAD 0.002%). This missense change has been observed in individual(s) with nemaline myopathy (PMID: 16917880, 27854218; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 242433). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on NEB function (PMID: 25110572). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Arthrogryposis multiplex congenita 6 Pathogenic:1
- -
Nemaline myopathy 2;C5543431:Arthrogryposis multiplex congenita 6 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: NEB c.7291G>A (p.Glu2431Lys) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 248946 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.7291G>A has been reported in the literature in at least one compound heterozygous individual affected with Nemaline Myopathy 2 (Lehtokari_2006). These data do not allow any conclusion about variant significance. At least one publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Marttila_2014). The following publications have been ascertained in the context of this evaluation (PMID: 16917880, 25205138, 25110572). ClinVar contains an entry for this variant (Variation ID: 242433). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Nemaline myopathy Uncertain:1
The p.Glu2431Lys variant in NEB has been reported, in the compound heterozygous state, in one individual with nemaline myopathy (PMID: 16917880), and has been identified in 0.005% (51/1111814) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs767302772). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools, including splice predictors and conservation analyses, suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Glu2431Lys variant is uncertain. ACMG/AMP Criteria applied: PM3, BP4, PM2_supporting (Richards 2015). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at